263 related articles for article (PubMed ID: 30657373)
21. Survival After Primary Debulking Surgery Compared With Neoadjuvant Chemotherapy in Advanced Ovarian Cancer: A National Cancer Database Study.
Seagle BL; Graves S; Strohl AE; Shahabi S
Int J Gynecol Cancer; 2017 Oct; 27(8):1610-1618. PubMed ID: 28763362
[TBL] [Abstract][Full Text] [Related]
22. Specialized care and survival of ovarian cancer patients in The Netherlands: nationwide cohort study.
Vernooij F; Heintz AP; Witteveen PO; van der Heiden-van der Loo M; Coebergh JW; van der Graaf Y
J Natl Cancer Inst; 2008 Mar; 100(6):399-406. PubMed ID: 18334710
[TBL] [Abstract][Full Text] [Related]
23. Association of gynecologic oncology versus medical oncology specialty with survival, utilization, and spending for treatment of gynecologic cancers.
Ko EM; Bekelman JE; Hicks-Courant K; Brensinger CM; Kanter GP
Gynecol Oncol; 2022 Feb; 164(2):295-303. PubMed ID: 34949437
[TBL] [Abstract][Full Text] [Related]
24. Influence of treatment center and hospital volume on survival for locally advanced cervical cancer.
Wright JD; Huang Y; Ananth CV; Tergas AI; Duffy C; Deutsch I; Burke WM; Hou JY; Neugut AI; Hershman DL
Gynecol Oncol; 2015 Dec; 139(3):506-12. PubMed ID: 26177552
[TBL] [Abstract][Full Text] [Related]
25. Characteristics and survival of cervical cancer patients managed at adjacent urban public and university medical centers.
Behbakht K; Abu-Rustum NR; Lee S; San Juan A; Massad LS
Gynecol Oncol; 2001 Apr; 81(1):40-6. PubMed ID: 11277647
[TBL] [Abstract][Full Text] [Related]
26. National Cancer Data Base/Surveillance Epidemiology and End Results: potential insensitive-measure bias.
Fanning J; Gangestad A; Andrews SJ
Gynecol Oncol; 2000 Jun; 77(3):450-3. PubMed ID: 10831358
[TBL] [Abstract][Full Text] [Related]
27. Adjuvant therapy in stage III endometrial cancer: treatment outcomes and survival. a single-institution retrospective study.
Kuku S; Williams M; McCormack M
Int J Gynecol Cancer; 2013 Jul; 23(6):1056-64. PubMed ID: 23765205
[TBL] [Abstract][Full Text] [Related]
28. Disparities in treatment and survival for women with endometrial cancer: A contemporary national cancer database registry analysis.
Fader AN; Habermann EB; Hanson KT; Lin JF; Grendys EC; Dowdy SC
Gynecol Oncol; 2016 Oct; 143(1):98-104. PubMed ID: 27470998
[TBL] [Abstract][Full Text] [Related]
29. Treatment and survival for women with Fallopian tube carcinoma: a population-based study.
Kosary C; Trimble EL
Gynecol Oncol; 2002 Aug; 86(2):190-1. PubMed ID: 12144827
[TBL] [Abstract][Full Text] [Related]
30. Disparities in gynecologic cancer incidence, treatment, and survival: a narrative review of outcomes among black and white women in the United States.
Towner M; Kim JJ; Simon MA; Matei D; Roque D
Int J Gynecol Cancer; 2022 Jul; 32(7):931-938. PubMed ID: 35523443
[TBL] [Abstract][Full Text] [Related]
31. Prognostic factors in endometrial clear cell carcinoma.
Cetinkaya N; Selcuk İ; Ozdal B; Meydanli MM; Gungor T
Arch Gynecol Obstet; 2017 Jan; 295(1):189-195. PubMed ID: 27549092
[TBL] [Abstract][Full Text] [Related]
32. Gynecologic cancer in HIV-infected women: treatment and outcomes in a multi-institutional cohort.
Levinson KL; Riedel DJ; Ojalvo LS; Chan W; Angarita AM; Fader AN; Rositch AF
AIDS; 2018 Jan; 32(2):171-177. PubMed ID: 29028665
[TBL] [Abstract][Full Text] [Related]
33. Primary cytoreductive surgery and adjuvant hormonal monotherapy in women with advanced low-grade serous ovarian carcinoma: Reducing overtreatment without compromising survival?
Fader AN; Bergstrom J; Jernigan A; Tanner EJ; Roche KL; Stone RL; Levinson KL; Ricci S; Wethingon S; Wang TL; Shih IM; Yang B; Zhang G; Armstrong DK; Gaillard S; Michener C; DeBernardo R; Rose PG
Gynecol Oncol; 2017 Oct; 147(1):85-91. PubMed ID: 28768570
[TBL] [Abstract][Full Text] [Related]
34. Gynecologic cancer disparities: a report from the Health Disparities Taskforce of the Society of Gynecologic Oncology.
Collins Y; Holcomb K; Chapman-Davis E; Khabele D; Farley JH
Gynecol Oncol; 2014 May; 133(2):353-61. PubMed ID: 24406291
[TBL] [Abstract][Full Text] [Related]
35. Survival of gynecological cancers in Turkey: where are we at?
Gultekin M; Dundar S; Kucukyildiz I; Karaca MZ; Boztas G; Turan SH; Hacikamiloglu E; Keskinkilic B
J Gynecol Oncol; 2017 Nov; 28(6):e85. PubMed ID: 29027403
[TBL] [Abstract][Full Text] [Related]
36. Lymphadenectomy in women with endometrial cancer: aspiration and reality from a radiation oncologist's point of view.
Foerster R; Kluck R; Arians N; Rieken S; Rief H; Adeberg S; Bostel T; Schlampp I; Debus J; Lindel K
Radiat Oncol; 2015 Jul; 10():147. PubMed ID: 26179059
[TBL] [Abstract][Full Text] [Related]
37. Survival Differences Among Uterine Papillary Serous, Clear Cell and Grade 3 Endometrioid Adenocarcinoma Endometrial Cancers: A National Cancer Database Analysis.
McGunigal M; Liu J; Kalir T; Chadha M; Gupta V
Int J Gynecol Cancer; 2017 Jan; 27(1):85-92. PubMed ID: 27759595
[TBL] [Abstract][Full Text] [Related]
38. Survival advantage associated with multimodal therapy in women with node-positive (stage-IIIC) uterine papillary serous carcinoma: a National Cancer Database study.
Lin JF; Muñiz K; Sukumvanich P; Gehrig P; Beriwal S; Kelley JL; Edwards RP; Olawaiye AB
BJOG; 2016 Oct; 123(11):1846-52. PubMed ID: 26537059
[TBL] [Abstract][Full Text] [Related]
39. Patterns of adjuvant radiation usage and survival outcomes for stage I endometrial carcinoma in a large hospital-based cohort.
Wong AT; Rineer J; Schwartz D; Weiner J; Safdieh J; Choi K; Schreiber D
Gynecol Oncol; 2017 Jan; 144(1):113-118. PubMed ID: 27823769
[TBL] [Abstract][Full Text] [Related]
40. The impact of age on long-term outcome in patients with endometrial cancer treated with postoperative radiation.
Jolly S; Vargas CE; Kumar T; Weiner SA; Brabbins DS; Chen PY; Floyd W; Martinez AA
Gynecol Oncol; 2006 Oct; 103(1):87-93. PubMed ID: 16545441
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
